BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 9715685)

  • 1. A model of the incidence and consequences of choroidal neovascularization secondary to age-related macular degeneration. Comparative effects of current treatment and potential prophylaxis on visual outcomes in high-risk patients.
    Lanchoney DM; Maguire MG; Fine SL
    Arch Ophthalmol; 1998 Aug; 116(8):1045-52. PubMed ID: 9715685
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Five-year follow-up of fellow eyes of patients with age-related macular degeneration and unilateral extrafoveal choroidal neovascularization. Macular Photocoagulation Study Group.
    Arch Ophthalmol; 1993 Sep; 111(9):1189-99. PubMed ID: 7689826
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Five-year follow-up of fellow eyes of individuals with ocular histoplasmosis and unilateral extrafoveal or juxtafoveal choroidal neovascularization. Macular Photocoagulation Study Group.
    Arch Ophthalmol; 1996 Jun; 114(6):677-88. PubMed ID: 8639078
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Persistent and recurrent neovascularization after laser photocoagulation for subfoveal choroidal neovascularization of age-related macular degeneration. Macular Photocoagulation Study Group.
    Arch Ophthalmol; 1994 Apr; 112(4):489-99. PubMed ID: 7512335
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk factors for choroidal neovascularization in the second eye of patients with juxtafoveal or subfoveal choroidal neovascularization secondary to age-related macular degeneration. Macular Photocoagulation Study Group.
    Arch Ophthalmol; 1997 Jun; 115(6):741-7. PubMed ID: 9194725
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Laser treatment in eyes with large drusen. Short-term effects seen in a pilot randomized clinical trial. Choroidal Neovascularization Prevention Trial Research Group.
    Ophthalmology; 1998 Jan; 105(1):11-23. PubMed ID: 9442774
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Choroidal neovascularization in the Choroidal Neovascularization Prevention Trial. The Choroidal Neovascularization Prevention Trial Research Group.
    Ophthalmology; 1998 Aug; 105(8):1364-72. PubMed ID: 9709744
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Visual outcome after laser photocoagulation for subfoveal choroidal neovascularization secondary to age-related macular degeneration. The influence of initial lesion size and initial visual acuity. Macular Photocoagulation Study Group.
    Arch Ophthalmol; 1994 Apr; 112(4):480-8. PubMed ID: 7512334
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Macular scatter ('grid') laser treatment of poorly demarcated subfoveal choroidal neovascularization in age-related macular degeneration. Results of a randomized pilot trial.
    Bressler NM; Maguire MG; Murphy PL; Alexander J; Margherio R; Schachat AP; Fine SL; Stevens TS; Bressler SB
    Arch Ophthalmol; 1996 Dec; 114(12):1456-64. PubMed ID: 8953976
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Occult choroidal neovascularization. Influence on visual outcome in patients with age-related macular degeneration. Macular Photocoagulation Study Group.
    Arch Ophthalmol; 1996 Apr; 114(4):400-12. PubMed ID: 8602776
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Argon green vs. krypton red laser photocoagulation for extrafoveal choroidal neovascularization secondary to age-related macular degeneration: 3-year results of a multicentre randomized trial. Canadian Ophthalmology Study Group.
    Willan AR; Cruess AF; Ballantyne M
    Can J Ophthalmol; 1996 Feb; 31(1):11-7. PubMed ID: 8925479
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of argon green vs krypton red laser for photocoagulation of subfoveal choroidal neovascularization in the macular photocoagulation study. Macular Photocoagulation Study (MPS) Group.
    Arch Ophthalmol; 1994 Sep; 112(9):1176-84. PubMed ID: 7522004
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Laser photocoagulation of subfoveal neovascular lesions of age-related macular degeneration. Updated findings from two clinical trials. Macular Photocoagulation Study Group.
    Arch Ophthalmol; 1993 Sep; 111(9):1200-9. PubMed ID: 7689827
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Verteporfin therapy for subfoveal choroidal neovascularization in age-related macular degeneration: three-year results of an open-label extension of 2 randomized clinical trials--TAP Report no. 5.
    Blumenkranz MS; Bressler NM; Bressler SB; Donati G; Fish GE; Haynes LA; Lewis H; Miller JW; Monés JM; Potter MJ; Pournaras C; Reaves A; Rosenfeld PJ; Schachat AP; Schmidt-Erfurth U; Sickenburg M; Singerman LJ; Slakter JS; Strong A; Vannier S;
    Arch Ophthalmol; 2002 Oct; 120(10):1307-14. PubMed ID: 12365909
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk factors for choroidal neovascularization and geographic atrophy in the complications of age-related macular degeneration prevention trial.
    Complications of Age-related Macular Degeneration Prevention Trial (CAPT) Research Group
    Ophthalmology; 2008 Sep; 115(9):1474-9, 1479.e1-6. PubMed ID: 18502512
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin: one-year results of 2 randomized clinical trials--TAP report. Treatment of age-related macular degeneration with photodynamic therapy (TAP) Study Group.
    Arch Ophthalmol; 1999 Oct; 117(10):1329-45. PubMed ID: 10532441
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The development of choroidal neovascularization in eyes with the geographic atrophy form of age-related macular degeneration.
    Sunness JS; Gonzalez-Baron J; Bressler NM; Hawkins B; Applegate CA
    Ophthalmology; 1999 May; 106(5):910-9. PubMed ID: 10328389
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Feeder vessel photocoagulation of subfoveal choroidal neovascularization secondary to age-related macular degeneration.
    Shiraga F; Ojima Y; Matsuo T; Takasu I; Matsuo N
    Ophthalmology; 1998 Apr; 105(4):662-9. PubMed ID: 9544641
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Laser treatment in patients with bilateral large drusen: the complications of age-related macular degeneration prevention trial.
    Complications of Age-Related Macular Degeneration Prevention Trial Research Group
    Ophthalmology; 2006 Nov; 113(11):1974-86. PubMed ID: 17074563
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Laser photocoagulation for juxtafoveal choroidal neovascularization. Five-year results from randomized clinical trials. Macular Photocoagulation Study Group.
    Arch Ophthalmol; 1994 Apr; 112(4):500-9. PubMed ID: 7512336
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.